13F Data
13F filer · CIK 1887785

Madrona Venture Group, LLC

SEATTLE, WA · filing since Q4 2020 · last filing Feb 13, 2026
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Reported value
$22.1M
+$8.2M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q3 2025

No new or increased positions this quarter.

Biggest sells vs Q3 2025

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $741.5MQ1 2021: $544.4MQ2 2021: $617.4MQ3 2021: $752.3MQ4 2021: $529.4MQ1 2022: $337.7MQ2 2022: $215.4MQ3 2022: $217.3MQ4 2022: $207.5MQ1 2023: $246.7MQ2 2023: $274.6MQ3 2023: $291.9MQ4 2023: $427.1MQ1 2024: $117.5MQ2 2024: $93.7MQ3 2024: $74.6MQ4 2024: $53.8MQ1 2025: $28.5MQ2 2025: $12.6MQ3 2025: $13.8MQ4 2025: $22.1M
Q4 2020Q4 2025

Holdings · Q4 2025

#SecuritySharesValueWeight
1NAUTILUS BIOTECHNOLOGY INCCOM6,020,770$11.7M53.24%
2UIPATH INCCL A607,673$10.0M45.16%
3GINKGO BIOWORKS HOLDINGS, INC.CL A42,430$353.0K1.60%